Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outlook Therapeutics (OTLK) Other Non-Current Assets: 2015-2020

Historic Other Non-Current Assets for Outlook Therapeutics (OTLK) over the last 4 years, with Jun 2020 value amounting to $1.4 million.

  • Outlook Therapeutics' Other Non-Current Assets rose 196.51% to $1.4 million in Q2 2020 from the same period last year, while for Jun 2020 it was $1.4 million, marking a year-over-year increase of 196.51%. This contributed to the annual value of $457,476 for FY2019, which is 6.84% down from last year.
  • Per Outlook Therapeutics' latest filing, its Other Non-Current Assets stood at $1.4 million for Q2 2020, which was up 165.00% from $540,834 recorded in Q1 2020.
  • In the past 5 years, Outlook Therapeutics' Other Non-Current Assets registered a high of $2.3 million during Q1 2016, and its lowest value of $440,339 during Q1 2019.
  • For the 3-year period, Outlook Therapeutics' Other Non-Current Assets averaged around $623,273, with its median value being $515,936 (2018).
  • As far as peak fluctuations go, Outlook Therapeutics' Other Non-Current Assets slumped by 63.95% in 2017, and later surged by 196.51% in 2020.
  • Over the past 5 years, Outlook Therapeutics' Other Non-Current Assets (Quarterly) stood at $830,887 in 2016, then declined by 25.29% to $620,786 in 2017, then declined by 25.53% to $462,326 in 2018, then rose by 21.72% to $562,748 in 2019, then spiked by 196.51% to $1.4 million in 2020.
  • Its Other Non-Current Assets stands at $1.4 million for Q2 2020, versus $540,834 for Q1 2020 and $562,748 for Q4 2019.